Ironwood, AstraZeneca sales and marketing update

Ironwood said in its 4Q12 earnings that it received rights from AstraZeneca to co-promote Nexium esomeprazole in the U.S. The proton pump inhibitor (PPI) delayed-release capsules are approved in more...